An IP Australia delegate has rejected German drug maker Ever Neuro Pharma’s claim that extensive experimental evidence was needed to prove the usefulness of a Parkinson’s drug developed by UK-based Britannia Pharmaceuticals.
A former manager at the NSW Roads and Maritime Services awarded over $12.2 million in government contracts to two companies owned by his friends, the NSW Independent Commission Against Corruption has found.
A judge has found that Uniden infringed rival GME’s design patent for a handheld radio, derailing the company’s plan for an Australian launch of two products.
A unit of Suncorp Group has reached an in-principle settlement in a class action over alleged conflicted remuneration on the first day of an expected 25-day trial.
Actor Craig McLachlan has dropped his defamation suit against the ABC, Fairfax and actress Christie Whelan Browne mid-trial just as the defence was due to start its case.
Mills Oakley has picked up a leading dispute resolution lawyer from Thomson Geer to join the firm’s not-for-profit team as partner.
A long-running class action over the Opal Tower disaster has settled, along with two related cases over the defective building, as a five-week trial was set to begin.
Shine Lawyers has beaten out class action rival Piper Alderman in a battle to lead a class action worth up to $463 million against collapsed wealth managers Dixon Advisory, with a judge finding the firm’s no win, no fee model was likely to result in a greater return to group members.
Regenerative medicine company Mesoblast is facing another class action over claims it misled shareholders about the potential application of a developmental stem cell product to treat terminally ill children.
The state of Victoria has asked a court to strike out a class action alleging lapses in its hotel quarantine program caused businesses to suffer losses when stage three and four COVID-19 restrictions were put in place between July and August 2020.